Clinical Trial Update: Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 comparative trial evaluating photodynamic therapy with triamcinolone versus photodynamic therapy with triamcinolone and ranibizumab for subfoveal ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subfoveal Choroidal Neovascularization

Drugs mentioned

• Ranibizumab (ranibizumab)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Subfoveal Choroidal Neovascularization | Phase 2, Phase 3 | Status: WITHDRAWN